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Aim: We sought to characterize the contribution of the O-OTase, PglL, to virulence in two Burkholderia
spp. by comparing isogenic mutants in Burkholderia pseudomallei with the related species, Burkholderia
thailandensis.Materials &methods:Weutilized an array of in vitro assays in addition toGalleriamellonella
and murine in vivo models to assess virulence of the mutant and wild-type strains in each Burkholderia
species. Results: We found that pglL contributes to biofilm and twitching motility in both species. PglL
uniquely affected morphology; cell invasion; intracellular motility; plaque formation and intergenus com-
petition in B. pseudomallei. This mutant was attenuated in the murine model, and extended survival in a
vaccine-challenge experiment. Conclusion: Our data support a broad role for pglL in bacterial fitness and
virulence, particularly in B. pseudomallei.
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The Burkholderiaceae family are comprised of an interesting group of mostly soil-dwelling saprophytes. They
have evolved diverse characteristics: some are able to fix nitrogen and are considered symbionts, others cause
rot in important food crops; some are bioremediators, and others are opportunistic pathogens of animals [1].
Melioidosis, the potentially fatal disease for humans caused by Burkholderia pseudomallei, is highly endemic in
Southeast Asia and northern Australia, and it is now clear that the bacteria can be isolated from soil found in
many subtropical countries around the world [2–5]. Climate change may yet introduce the organism to regions
where it was previously absent [6]. Hence, melioidosis can be considered both a neglected and an emerging public
health concern. B. pseudomallei is also considered a tier one select agent by the Centres for Disease Control and
Prevention. Understanding why this species in particular is so virulent in humans is therefore a research priority.
While we have uncovered many of the molecular aspects that facilitate pathogenesis [7], the potential contribution
of post-translational protein glycosylation to virulence is comparatively under studied. Previously considered solely
a feature of higher organisms, protein glycosylation is now understood to be common among prokaryotes [8], and
can contribute to protein folding, stability, trafficking, function and immunogenicity [9].
Glycosylation systems are primarily defined by two aspects: first, the type of bond that connects the glycan to the
amino-acid – a covalent link to either an amide nitrogen of an asparagine residue (N-linked glycosylation), or to a
hydroxyl oxygen usually in a serine/threonine residue (O-linked glycosylation). Secondly, the mechanism by which
the glycan is coupled to the peptide. This occurs either iteratively, with monosaccharides sequentially attached to
an acceptor protein, a process enabled by a cytosolic glycosyltransferase; or as en bloc transfer of polysaccharides
from a lipid carrier, typically UndPP [10], enabled by a periplasmic OTase [11,12].
PglL is one of the few types of O-linked OTases so far discovered; it is homologous to PilO in Pseudomonas
aeruginosa, but PilO is limited to the transfer of relatively short chain-length oligosaccharides [12]. PglL was first
identified in a Burkholderia spp. in 2012 [13], and recently has been shown to be well conserved across the genus,
typicallymodifying peptides with two trisaccharide glycans: HexNAc-HexNAc-262 andHexNAc-HexNAc-Hex [14]
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Detection of novel O-OTases is hampered by the fact that they contain a Wzy-C domain in common with
those found in WaaL ligases [15], often leading to mis-annotation. Thus, O-OTase activity must be demonstrated
experimentally for definitive assignment. By expressing meningococcal PglL in Escherichia coli, it was demonstrated
that this enzyme could glycosylate Type IV pilin, microfilamentous cell-surface structures that confer twitching
motility [12]. Pilin glycosylation, which can also be mediated by PilO, has been shown to contribute to: biofilm
formation [16]; host-cell attachment [17]; defense against bacteriophage [18]; and resistance to surfactant proteins [19].
Interestingly, Acinetobacter spp. strains have recently been discovered that express more than one type of pilin
glycoprotein [20], and some possess two functional PglL proteins, one thought to be dedicated to pilin glycosylation
and the other to multiple other glycoproteins [21]. It is interesting to note that although pglL itself is conserved,
the number and identity of glycoproteins dependent on its activity differs between Burkholderia species. For
example, 23 unique glycoproteins have been identified in Burkholderia cenocepacia dependent on pglL [11], with
29 in Burkholderia gladioli; eight in Burkholderia thailandensis and ten in B. pseudomallei [14]. In B. cencocepacia
these glycoproteins contribute to diverse functions including cell division; stress response; membrane transport;
and virulence. A specific pglL mutant in B. cenocepacia has been shown to have an altered phenotype relating to
aspects of virulence, metabolic activity and sensitivity to oxidative and osmotic stress [14].
The available evidence suggests that PglL might play an influential role in the microbiology and virulence of B.
pseudomallei. We therefore constructed unmarked deletion mutants of pglL for comparison in the mainly avirulent
species, B. thailandensis E264 (bth 0650) and in B. pseudomallei K9264 (bpsl0783). Through characterization in a
range of in vitro and in vivo assays, we sought to understand its potential contribution to fitness and virulence. We
report that pglL is required for virulence in Burkholderia spp. in a species-restricted manner, including the discovery
of novel phenotypes not previously attributed to the function of this gene.
Materials & methods
Cell lines & culture conditions
RAW 264.7 murine macrophage-like cells and A549 human epithelial cell lines were both sourced from ATCC
(LGCStandards,Manchester, UK) andmaintained in sterile RPMI 1640Glutamax supplemented with 10%bovine
fetal calf serum (both Thermo Fisher Scientific, Gloucester, UK). Cell were cultured at 37◦C in an atmosphere of
5% CO2.
sacB mediated unmarked gene deletion mutagenesis
ForB. thailandensispglLmutagenesis, 1 kb downstream andupstreamhomologousDNA fragments toBTH I0650
(pglLBthai) were amplified using PhusionHigh-Fidelity polymerase chain reaction (PCR) master mix with GC buffer
with 3% dimethyl sulfoxide (DMSO) (Finnzyme, #F532) from purified genomic DNA (DNAEasy, Qiagen).
These fragments were assembled in a splicing-by-overlapping-extension PCR (SOE-PCR) and purified using a
gel extraction kit (Qiagen). For B. pseudomallei (pglLBPS), the upstream and downstream dsDNA fragment was
synthesized by GenScript (NJ, USA).
The inserts were ligated into the pJET1.2 blunt cloning vector (Fermentas#K1231) and transformation was
performed on chemically competent E. coli Top10 cells (Invitrogen #C4040-50). Clones were screened by PCR
and sequencing. The deletion construct was subcloned into the XbaI-digested dephosphorylated pDM4 vector
via the restriction sites and transformed into pir+ E. coli EC100D (Epicenter) for antibiotic selection of positive
colonies in LB agar with chloramphenicol. The pDM4 construct was then subcloned into electrocompetent E. coli
MFD cells for conjugation with Burkholderia spp.
Overnight cultures of the donor strain and the recipient strain were washed once with sterile phosphate-buffered
saline (PBS) and mixed in a 1:3 volume ratio. 100 μl of the mixture was applied to a prewarmed LB agar plate
containing diaminopimelic acid (DAP) and incubated for no longer than 16 h at 37◦C. Cells were resuspended
and serially diluted in PBS and cultured overnight at 37◦C on selective LB agar containing chloramphenicol. B.
thailandensis and B. pseudomallei colonies were screened for presence of the deletion fragment.
Overnight culture of the merodiploid strain was diluted in PBS and 100 μl was plated on salt-free LB agar
containing 10–12% (w/v) sucrose. The plate was incubated at 24◦C until colonies were well grown. Colonies were
screened for chloramphenicol sensitivity; independent sensitive colonies were then screened first using colony PCR
and then selected for whole-genome next generation sequencing (performed by Public Health England, Genomic
Services and Development Unit, London, UK) to confirm deletion at the intended site (Supplementary Figure 4).
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Antibiotic & complement assays
For each condition, wild-type B. pseudomallei K96243; B. thailandensis E264; B. pseudomallei pglL and B.
thailandensis pglL were cultured overnight from a single colony in 5 ml sterile Luria–Bertani (LB) broth at 37◦C
with shaking. All strains employed in this study exhibited comparable growth rates when cultured in the media
used. Bacteria concentrations were standardized by adjusting to an OD590 of 1 and then further diluted 1:100 in
fresh LB. A total of 10 μl of bacterial solutions were added in triplicate to flat bottom 96-well plates containing
100 μl of titrated polymixin B or human serum (both, Sigma-Aldrich, Gillingham, UK) at the concentrations
described. For heat inactivation, human serum was incubated at 65◦C for 1 h. After 24 h incubation at 37◦C,
colony-forming unit (CFU) assay was performed by serial dilution of each sample well in sterile phosphate-buffered
saline (PBS; Sigma, UK) before plating on fresh LB-agar and incubation for a further 24 h at 37◦C for colony
enumeration.
Biofilm & twitching motility assay
Biofilm formation was assessed using the 96-well plate and accompanying peg-lid of the MBEC assay device
(Innovotech, Farnborough, UK), as described by Denman and Brown [22]. Cultures were incubated statically at
37◦C (biofilm assay) or at room temperature (twitching assay). To assess twitching motility, bacteria were first
streaked onto sterile LB agar and incubated overnight. A small portion of similar size from each strain was picked
from the outer edge of the colonies with a sterile 10 μl pipette tip and homogenized. The tip was then used to
perpendicularly stab the centre of triplicate fresh 1% LB agar plates, and moved up and down three times to ensure
bacterial transfer. Plates were inverted and incubated at room temperature (RT) until a visible interstitial colony
could be observed between the plastic of the Petri dish and the agar layer. The agar was then removed from the
Petri dish, and the diameter of the colonies on the plastic measured for calculation of average circumference.
Cell infection assay
Either A549 epithelial cells or RAW 264.7 cells were seeded at a concentration of 1 × 105 per 100 μl in sterile flat
bottom 96-well plates in RPMI, 10% fetal calf serum (FCS) overnight at 37◦C, 5% CO2. These cells were then
infected for 90 min with fresh Burkholderia strains cultured overnight at a multiplicity of infection (MOI) of five.
At 90 min (T = 0), cells were washed three times with sterile PBS prior to cell lysis with 0.5% Triton X100 in water
for 30 min followed by mechanical disruption by pipetting. For later time points, cells were instead incubated in
a medium of RPMI 10% FCS with 100 μg ml-1 kanamycin to control extracellular replication, this dose has been
shown by others to completely kill extracellular B. pseudomallei and B. thailandensis [23]. After lysis at each time
point, as well as from the input infection solution, bacterial CFU were enumerated by serial dilution and culture
on LB agar overnight at 37◦C.
Confocal microscopy
A549 epithelial cells were seeded at a concentration of 1 × 105 cells per 100 μl RPMI 10% FCS into Lab-Tek
II Chamber Slides (Thermo Fisher Scientific, Gloucester, UK) and incubated overnight at 37◦C with 5% CO2.
These were infected with different MOI of each Burkholderia strain as indicated. After 90 min incubation at
37◦C, the monolayer was washed with sterile PBS and media replaced with fresh RPMI 10% FCS with 100 μg
ml-1 kanamycin to control extracellular replication. Chamber slides were then incubated for a further 20 h at
37◦C with 5% CO2. Media was gently removed and the cells washed twice with sterile PBS before fixation with
freshly prepared 4% paraformaldehyde for 1 h. Cells were permeabilized using 0.1% Triton X100 in PBS for
15 min at RT and then washed twice with PBS. Fcγ receptor was blocked using 10% goat serum for 30 min
before incubation with primary antibody (a kind gift from Prof Richard Titball, University of Exeter, UK) for 1
h prior to two PBS washes and incubation with AlexaFluor 488 goat anti-mouse IgG (H+L) secondary antibody
(Thermo Fisher Scientific) along with 20 units/well AlexaFluor 546 phalloidin (Thermo Fisher Scientific) for 1
h. To mount the cells, the media was drained and the chambers removed from the glass slide. Monolayers were
allowed to dry briefly before addition of Vectashield anti-fade mounting medium with DAPI (Vector Laboratories,
Peterborough, UK) and attachment of the coverslip. All images were captured using a Zeiss LSM 880 confocal
microscope with Plan-Apochromat 63x/1.4 Oil DIC M27 using standard confocal mode driven by ZEN Black
2.3 software (Carl Zeiss). 2x3 tile scan z-stacks were captured and stitched together using a 10% overlap. DAPI was
visualized using a 405 nm laser and collection of light at 410–495 nm; phalloidin was visualized using a 561 nm
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laser and collection of light at 574–712 nm and AlexaFluor 488 was visualized using a 488 nm laser with collection
of light at 499–571 nm.
Plaque quantification was determined manually, with values representing the average number from duplicate
wells of an eight-well chamber slide. We defined a plaque as a space greater than 100 μM in diameter absent of any
A549 cells. For actin tail length measurement, we utilized Zeiss Zen 2.3 software tools.
Competition assay
To prepare E. coli, chemically competent TOP10 strains (Thermo Fisher Scientific) were transformed with pcDNA
3.3 TOPO LacZ and plated onto dry LB agar precoated with 50 μl X-gal at 40 μg ml-1. A blue colony was
selected and cultured overnight in 5 ml LB broth containing 100 μg ml-1 ampicillin. All Burkholderia colonies
were cultured in LB broth. Optical density of all strains were standardized to an OD590 of one, centrifuged and
resuspended in 200 μl sterile LB broth. A total of 30 μl of E. coli were mixed with 30 μl Burkholderia spp. from
each strain in triplicate. These mixtures were cultured for 5 h at 37◦C either in static liquid LB broth, or spotted
onto LB agar. After 5 h the bacteria growing on agar were scraped and resuspended in 1 ml sterile PBS. For all
conditions, including the input cultures, serial dilution was performed and bacteria spotted onto X-gal LB agar for
CFU enumeration and calculation of blue:white (E. coli:Burkholderia spp.) ratios.
Galleria mellonella larval infection
Following growth of bacteria in LB, infection of larvae with 1 × 104 CFU was performed as described by Wand
et al. [22,24,25], and larval survival monitored over a 72 h period. Live versus dead was determined by melanisation,
and response to touch with a pipette tip.
Mouse infection & vaccination
For all murine studies, female BALB/c mice (Charles Rivers Laboratories International, Kent, UK) were used with
the approval of the local Ethical Review Committee and in accordance with the Animals (Scientific Procedures) Act
of 1986. For each infection, mice were first anesthetized intraperitoneally with a ketamine (100 mg kg-1; Ketalar,
Pfizer Ltd, Surrey, UK) and xylazine (10 mg kg-1; Rompun, UK) solution diluted in sterile saline. Infection inocula
were administered by pipetting a total of 50 μl into both nostrils.
For vaccination, mice were first inoculated intranasally with varying CFU of B. pseudomallei pglL mutant or
sterile PBS as described with six mice per group. After 4 weeks, all mice were challenged with 500 CFU wild-
type B. pseudomallei K96243. Surviving mice at the end of the experiment were culled to enable post-mortem
enumeration of bacteria in lungs and spleen by CFU assay. PCR was conducted on the resultant colonies using
Advantage GC DNA polymerase (Takara Bio, Clontech, UK) with the manufacturer’s recommended protocolto
confirm the proportion of wild-type versus mutant strain by amplification of the pglL gene (forward primer: 5′
AACGTGCACTACCATCTCGG 3′; reverse primer: 5′ TTTCGCGAGCAGATCGATGA 3′).
Statistical analysis of data
All numerical data were collated and analyzed using GraphPad Prism 8.1.2. or Microsoft Excel 2016. Individual
statistical tests are described in the figure legends. Unless otherwise stated, figures represent the means of triplicate
technical repeats from three independent biological replicates.
Results
PglL genetics
We compared the arrangement of genes close to pglL in B. thailandensis E264 and B. pseudomallei K9264 (using
ATCC 700388 and GenBank assembly accession GCF 000011545.1, respectively; Supplementary Figure 1 &
Supplementary Table 1), and found them to be highly syntenic, with an identical arrangement of upstream and
downstream genes. As with the majority of the Burkholderia strains with publicly available genomes, a pili/fimbrae
related family protein is located directly upstream of the pglL coding sequence. We also conducted a phylogenetic
analysis of the PglL amino acid sequences alongside other Burkholderia spp. (Supplementary Figure 2) and found
several clusters. PglL from B. thailandensis was more closely related to orthologues from species that can cause
infection in humans and horses, B. pseudomallei and Burkholderia mallei, respectively, than it was to members of
the Burkholderia complex that mainly consist of plant pathogens and saprophytes. Finally, we examined amino
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Figure 1. Biofilm formation in wild-type and pglL Burkholderia spp. B. thailandensis E264 (A) or B. pseudomallei
K9264 (B) strains were incubated statically in peg-assay 96-well plates as described at 37◦C for 48 h. Biofilm formation
was assessed by crystal violet staining and measurement of optical density at 550 nm. Student’s t-test was performed
for each species’ wild-type versus the mutant strain using GraphPad Prism 8.1.2. Error bars represent standard
deviation from the mean of seven technical repeats. A representative figure from three independent biological
replicates is shown for each species.
***p < 0.001.
acid conservation and found PglL to be 95% identical over 96% of the sequence, although some nonsynonymous
mutations, insertions and deletions were identified (Supplementary Figure 3).
PglLBurk contributes to biofilm formation & twitching motility
In order to characterize the PglLBurk mutants in B. pseudomallei and B. thailandensis, we first utilized cell-free in vitro
based assays to determine phenotypes that may be affected by deletion of the O-OTase pathway. Pilin, a reported
target for glycosylation by PglL has been shown to promote biofilm formation and twitching-based motility. We
examined the ability of the strains to adhere to an abiotic surface in the form of polypropylene pegs at 37◦C over
48 h. pglLBthai was significantly attenuated in its ability to form biofilms, although it was still capable of adhering
to the peg surface (Figure 1A). The pglLBPS mutant also showed reduced biofilm formation (Figure 1B). These
data suggest that PglL supports, but is not essential for biofilm formation in either Burkholderia species.
We also assessed twitching motility, by measuring the mean circumference of colonies growing between an
agarose and a plastic surface. For both Burkholderia spp., the wild-type strains had significantly greater colony size
compared with the pglL mutant, indicating an important contribution of PglL to twitching motility (Figure 2A
& B).
PglLBPS promotes resistance to cell surface stress
Since PglL may modulate proteins expressed at the cell surface, we examined the sensitivity of the strains to cell
surface attack.
The pglLBPS mutant was more sensitive than wild-type to killing mediated by complement proteins in human
serum at concentrations above 12% (Figure 3A & B), a conclusion supported by the lack of killing when human
serum was heat treated to denature complement in the serum (Figure 3C & D). Interestingly, the wild-type B.
thailandensis strain was more sensitive complement mediated killing than even the pglLBPS mutant, and deletion
of pglLBthai enhanced resistance to attack.
Polymixin B, a cationic peptide, was significantly more toxic to pglLBPS than to the wild-type strain, while the
pglLBthai mutant was equally sensitive to polymyxin B as the wild-type (Figure 3E–F). At higher concentrations
of polymyxin B, there was no significant difference between the pglLBPS mutant and wild-type strain.
PglLBPS is required for efficient cell invasion & intracellular survival
Attachment and adherence to surfaces is the first step toward host–cell invasion, and an important aspect of
Burkholderia spp. virulence. Considering the observed influence of pglL on biofilm formation, we wanted to
understand whether there would be a similar contribution to eukaryotic cell adhesion. While the pglLBthai
mutant displayed no distinguishable phenotype compared with wild-type B. thailandensis, the pglLBPS mutant
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Figure 2. Twitching motility of wild-type and pglL Burkholderia spp. B. pseudomallei K9264 (A) or B. thailandensis
E264 (B) strains were grown between a plastic-agarose interface at room temperature and resultant mean colony
circumference measured. Student’s t-test was performed for each species’ wild-type versus the mutant strain using
GraphPad Prism 8.1.2. Error bars represent standard deviation from the mean of triplicate technical repeats. A
representative figure from three independent biological replicates is shown.
***p < 0.001.
was severely impaired in its ability to invade host cells (Figure 4A). This was particularly acute when an A549
epithelial cell monolayer was used, although the mutant was also deficient in RAW 264.7 cell entry. Following
uptake, the pglLBPS mutant was subsequently attenuated in intracellular survival in RAW 264.7 macrophage-
like cells compared with wild-type B. pseudomallei (Figure 4B). pglLBthai was not significantly impaired in its
intracellular survival.
PglLBPS is required for efficient actin tail assembly, cell division & plaque formation in A549
epithelial cell monolayers
Having established altered host–pathogen interaction in the pglLBPS mutant, we wanted to further examine its
role in virulence by utilizing confocal immunofluorescence to visualize interaction of the bacteria with a confluent
A549 cell monolayer. Both the B. pseudomallei and B. thailandensis wild-type strains, as well as the pglLBthai
mutant were capable of inducing multiple large plaques in the monolayer, in an MOI-dependent manner, and
could readily polymerise host-cell actin to form characteristic ‘comet tail’ structures (Figure 5A & B). Mean actin
tail length generated by wild-type B. thailandensis was significantly shorter than those generated by wild-type B.
pseudomallei (at 3916 and 2204 nm, respectively; Figure 6B). In the pglLBPS mutant, actin tail formation was
rarely detected, and the mean length of those tails was significantly shorter than in either wild-type species, at just
30 nm.
Plaque formation was not readily apparent when RAW 264.7 macrophages were used (data not shown). Bacteria
appeared to be mostly concentrated at the perimeter of the plaques in A549 cells, and many appeared to be in
the process of cell division. By contrast, deletion of pglL in B. pseudomallei resulted in significantly reduced and
truncated actin tail formation, with severely restricted plaque formation. In agreement with our cell infection assay,
very few pglLBPS bacteria were observed intracellularly after a 16 h infection. Additionally, those bacteria that
were present exhibited a severe cell-separation defect to form filamentous chains of bacilli (Figure 6A).
PglLBPS contributes to inter-species bacterial competition
The observation that the pglLBPS mutant was unable to efficiently induce actin tails or induce plaque formation
suggested a possible role for PglL in Type III and/or Type VI secretion system-mediated virulence. We chose to
investigate this aspect further by establishing an in vitro assay to study inter-species bacterial competition; when
cocultured on an agarose surface, competition between bacteria is greatly enhanced by the presence of a functional
Type VI secretion system.
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Figure 3. Sensitivity of wild-type and pglL Burkholderia spp. to Polymixin B and serum. B. thailandensis E264 or B. pseudomallei
K9264 strains were incubated with a titration of either human serum (A & B); heat-treated serum (C & D); or polymixin B (E & F).
Alternatively, human serum was heat inactivated by treatment at 65◦C for 1 h. Student’s t-test was performed for each species’ wild-type
versus the mutant strain within each condition using GraphPad Prism 8.1.2. Error bars represent standard deviation from the mean of
triplicate technical repeats. A representative figure from three independent biological replicates is shown.
*p < 0.05; **p < 0.01; ***p < 0.001.
CFU: Colony-forming unit.
There was no significant difference in the CFU of E. coli when cocultured in broth with either the pglL mutant
(of either species) or the wild-type (Figure 7). However, on agarose, there were significantly fewer E. coli when
cocultured with wild-type B. pseudomallei than with the pglL mutant, despite there being no significant difference
in the CFU of Burkholderia spp. This is suggestive of a defect in interbacterial competition in the pglL mutant in
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Figure 4. Attachment, uptake and intracellular survival of wild-type and pglL Burkholderia spp. Burkholderia spp.
strains were used to infect either human epithelial A549 cells or murine Raw 264.7 cells at an multiplicity of infection
of five for 90 min before washing, lysis and enumeration of bacteria by colony-forming unit assay (A). Raw 264.7 cells
were infected for longer time periods as described, with kanamycin used to control extracellular bacterial replication.
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Student’s t-test of wild-type versus mutant within each group was performed using GraphPad Prism 8.1.2. Error bars
represent standard deviation from the mean of triplicate technical repeats. A representative figure from three
independent biological replicates is shown.
**p < 0.05; ***p < 0.001.
WT: Wild-type.
B. pseudomallei. For B. thailandensis, there were significantly fewer pglL mutant and E. coli bacilli cocultured on
agarose.
PglLBURK is a key regulator of virulence in vivo
Having observed several effects of pglL deletion in vitro, we hypothesized that the mutants might be attenuated in an
in vivomodel of infection. Since B. thailandensis is avirulent in the murine model, we utilized a previously validated
approach of infection using G. mellonella wax-moth larvae as the host organism. Both wild-type B. thailandensis
and pglLBthai were able to kill all G. mellonella within 30 h, but infection with the mutant was able to significantly
extend the time until death for the majority of the larvae (Figure 8A).
Using a murine model of acute melioidosis [26], we identified that the pglLBPS mutant was significantly
attenuated (Figure 8B). When infected intranasally with approximately 1000 CFU of wild-type B. pseudomallei,
all mice developed clinical signs consistent with melioidosis infection and were culled after 4 days. By contrast, all
mice infected with the pglLBPS strain were active and healthy at 30 days, when the experiment was terminated.
To establish whether or not the animals had eradicated the infection, we assessed the organ load of B. pseudomallei
in both lungs and spleens (Figure 8C). Our data show that three out of five mice achieved sterility within the time
limit of the experiment, and had resolved the infection completely. The remaining twomice both retainedpglLBPS
bacilli in the spleen, and one mouse also retained viable bacteria in the lung despite being clinically healthy.
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Figure 5. Plaque formation by wild-type and pglL Burkholderia spp. In an A549 cell monolayer. Burkholderia spp. strains were used to
infect a confluent monolayer of A549 cells in chamber slides. After 90 min infection at different multiplicity of infections, cells were
incubated in the presence of 100 μg ml-1 kanamycin for a further 16 h. Immunofluorescence with confocal microscopy was used to image
the monolayers, with nuclei stained with DAPI (blue), host-cell actin cytoskeleton was stained with phalloidin alexafluor 546 (red) and
bacteria visualized using an alexafluor 488 secondary antibody (A). For counting, plaques were visualized using phase-contrast
microscopy and the entire well of duplicate wells was used for counting for each condition (B). Student’s t-test of wild-type versus mutant
was performed within each species and multiplicity of infection group using GraphPad Prism 8.1.2. Error bars represent standard
deviation from the mean of duplicate technical repeats. A representative figure from two independent biological replicates is shown.
***p < 0.001.
WT: Wild-type.
Vaccination with B. pseudomallei pglL enables the murine host to mount an improved protective
immune response against subsequent lethal-dose acute B. pseudomallei wild-type infection
Since we demonstrated that pglLBPS was severely attenuated in mice, and the majority cleared the infection from
the host, we were interested to establish whether it may provide proof of concept as a potential candidate for
vaccination against B. pseudomallei infection. To attempt a scenario whereby the host was able to reproducibly clear
the pglLBPS infection before challenge with wild-type B. pseudomallei, we experimented by reducing the inoculum
of the mutant to 500, 250 and 100 CFU for the vaccination experiment. Interestingly, we observed an inoculum
dose-dependent protective effect of vaccination with pglLBPS (Figure 9A). While mice that received the lowest
and highest dose of the mutant did not survive significantly longer than the saline-treated control group, those that
received a moderate dose of 250 CFU pglLBPS had significantly extended time until death. On average, the mice
lost weight following challenge with wild-type B. pseudomallei; however mice vaccinated with 250 CFU pglLBPS
showed either no or limited weight loss, reflecting their reduced disease severity (Figure 9B).
Surviving mice were culled at 35 days post-challenge so that organ bacterial burden could be examined. By using
PCR to distinguish the strains of B. pseudomallei, we found that all surviving mice harbored a mixed infection of
both pglLBPS and wild-type B. pseudomallei (Figure 9C), consistent with our previous finding that mutant strain
could not be consistently cleared by the host. The numbers of mutant to wild-type bacteria were approximately
equal, and in some cases the wild-type strain was the most prevalent.
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Figure 6. Actin-tail formation by wild-type and pglL Burkholderia spp. in an A549 cell monolayer. Burkholderia spp. strains were used
to infect a confluent monolayer of A549 cells in chamber slides. After 90 min infection at different multiplicity of infections, cells were
incubated in the presence of 100 μg ml-1 kanamycin for a further 16 h. Immunofluorescence with confocal microscopy was used to image
the monolayers, with nuclei stained with DAPI (blue), host-cell actin cytoskeleton was stained with phalloidin alexafluor 546 (red) and
bacteria visualized using an alexafluor 488 secondary antibody (A). To measure actin tails, Zeiss Zen software was used, and the results
displayed as a scatter chart (B). Mean lengths were: BPS WT 3916 nm (n = 106); BPS pglL 3 nm (n = 43); Bthai WT 2204 nm (n = 86); Bthai
pglL 2222 nm (n = 112). Statistical difference between mutant and wild-type for each species was determined by Mann–Whitney U test
using GraphPad Prism 8.1.2.
****p < 0.0001.
Discussion
By creating isogenic marker-less deletion mutants of the pglL gene in the avirulent species, B. thailandensis and in
the human pathogen, B. pseudomallei, we were able to characterize its contribution to fitness and virulence among
the Burkholderiaceae.
The pglLmutant in both species appeared to have pleiotropic effects. Loss of pglL negatively impacted biofilm
formation and twitching motility in both species. Considering the close proximity of pglL to pilA, and that this is a
reported target for glycosylation by pglL in other species, our data are consistent with a role for PglL in pilin-related
function. While pglL significantly contributed to biofilm formation on abiotic surfaces, it was not completely
abolished in the mutant strains. PilA-independent adherence in B. pseudomallei K96243 has been suggested by
Boddey et al. [27]. PilA is also implicated in supporting twitching motility [28], and our data suggest that pglL
supports this phenotype in both species. These findings are interesting in the context of the work of Lithgow et al.
and Mohamed et al., who did not identify pilin as one of the glycoproteins dependant on pglL, although there may
be technical challenges in isolating these fragile structures [11,14].
Besides these two shared phenotypes, deletion of pglL resulted in species-restricted outcomes. The efficient
attachment to and invasion of host cells by B. pseudomallei has been shown to rely on type IV pilin [29], as well as
a functional type III secretion system (T3SS) [30]. We found that the PglLBPS, but not the PglLBthai mutant was
defective in cell invasion in A549 epithelial-like cells. The fact that the phenotype was more apparent with A549
cells, which are non-phagocytic, than in RAW 264.7 macrophage-like cells implies that the PglLBPS is specifically
involved in attachment and invasion rather than via uptake mediated by ligation of host pattern recognition
receptors.
The pglLBPS mutant also demonstrated attenuated intracellular survival after 2 h in macrophage-like cells,
whereas the pglLBthai mutant did not. Here also, the T3SS has been shown to be essential, as it is required for
evasion of phagosomal [31] and autophagosomal [32] maturation. It was interesting to observe that more wild-type
B. thailandensis bacteria were present in infected cells after 16 h than wild-type B. pseudomallei, the more virulent
species, however others have reported similar findings [33]. The important role of the T3SS in cellular invasion and
early intracellular survival of B. pseudomallei is well established – our findings now support that pglL has similar
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Figure 7. Competition assay between wild-type or pglL Burkholderia spp. and E. coli. Burkholderia spp. strains were cocultured with E.
coli pcDNA 3.3 TOPO LacZ at identical optical densities for 5 h in either LB broth or spotted onto LB agar, as indicated. Bacteria were
enumerated by colony-forming unit assay on agar plates coated with X-gal for distinguishing bacterial species by blue/white screening.
Student’s t-test was performed for each species’ wild-type versus the mutant strain within each condition. Using GraphPad Prism 8.1.2.
Error bars represent standard deviation from the mean of triplicate technical repeats. A representative figure from three independent
biological replicates is shown.
*p < 0.05; ***p < 0.001.
CFU: Colony-forming unit; WT: Wild-type.
relevance. Further work is required to establish whether there is a direct connection between secretion system
activity and O-linked glycosylation, or whether they function as independent virulence factors.
By utilizing immunofluorescence, we were able to visualize additional aspects of infection that can result in
tissue pathology in the host. The primary antibody that we used was raised against B. pseudomallei K96243 strain,
which cross-reacted with B. thailandensis E264 – suggesting the conserved Type II O-antigen [34] may be the target
epitope. Only in the pglLBPS mutant, we observed reduced intracellular survival, actin-tail defects, abrogated
plaque formation and a cell division deformity. Actin-tail formation was less efficient in wild-type B. thailandensis
than B. pseudomallei, supporting published observations that B. thailandensis utilises an alternative mechanism to
induce host actin polymerisation [35]. In both species however, the upstream events rely on effectors of the T3SS
to facilitate phagosomal escape, before the autotransported protein, BimA, with BimC, recruit the necessary actin
polymerisation complexes at the poles of the bacillus [36]. Actin-tail formation in the pglLBPS mutant was very
rare, and when it occurred, the actin-tail length was significantly truncated. This suggests that at least some of the
pglLBPS bacilli could escape the phagosomal vacuole, but were thereafter impaired in their ability to polymerise
actin.
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Cell-to-cell spread of B. pseudomallei, cell fusion, giant-cell formation and ultimately, plaque formation are
dependent on the type VI secretion system (T6SS) [37]. T6SS are fairly widespread among Gram-negative bacteria,
having been identified in around one quarter of sequenced isolates [38,39]. In the extracellular environment, they
facilitate interspecies bacterial competition [40] while in the intracellular compartment, they have been reported as
having a role in phagosomal escape and in cytoplasmic replication [41–43]. Lack of plaque formation by thepglLBPS
mutant could have been simply due to its reduced ability to survive intracellularly, we therefore conducted an in
vitro competition assay to further explore a role for PglL in T6SS function.
The T6SS depends upon very close proximity for the effective injection of toxins into prey species, and so its
activity is restricted to solid surface or biofilms [44]. Therefore in our experiment when E. coli was cocultured with
B. pseudomallei in LB broth, when growth was planktonic, the E. coli could evade T6SS-mediated killing; we found
no significant difference in E. coli CFU in coculture with either pglLBPS or wild-type in this condition. However,
on an agarose surface, Burkholderia spp. could effectively kill the E. coli, pointing to an active T6SS. Deletion of
pglLBPS significantly perturbed this ability, with approximately 2.5 logs greater E. coliCFU after coculture compared
with the wild-type. Since the CFU of the Burkholderia wild-type and mutant was not significantly different on
agarose, our results suggest the defect lies in attenuated bactericidal activity, and not a general growth defect in the
mutant.
We also observed distinct morphological differences relating to aberrant cell division between the pglLBPS
mutant and the wild-type strain in A549 cells. Lack of pglLmight affect cell wall integrity in themutant in numerous
ways. For example, through altered expression and/or trafficking of cell surface lectins [16] and glycoproteins that
might otherwise accumulate in the periplasm. Furthermore, since PglL transfers oligosaccharide from the UndPP
carrier [45], its deletion may prevent recycling of UndPP for use as a carrier of peptidoglycan, lipopolysaccharide
or capsule precursors, stalling the biosynthesis of these structures. It should be noted however, that a pglL mutant
in B. cenocepacia was recently shown to have no defect in polymeric O-antigen biosynthesis [14]. Non-specific
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Figure 9. Vaccination of female BALB/C mice with pglL B. pseudomallei and challenge with wild-type BPS K9264.
Female BALB/C mice (n = 6 per group) were infected intranasally with different colony-forming unit of BPS pglL as
indicated, and after 28 days, challenged intranasally with wild-type BPS K9264. Survival (A) and body weight (B) were
monitored up to 68 days post vaccination. At 68 days, surviving mice (from the 250 CFU vaccinated group) were culled
and strains of organ-resident bacteria identified by polymerase chain reaction for the pglL gene to establish the ratio
of wild-type (challenge strain) to pglL (vaccine strain) colonies (C).
***p < 0.01 Log-rank Mantel-Cox and Gehan-Breslow-Wilcoxon test.
CFU: Colony-forming unit; ND: Excluded due to splenomegaly.
perturbation of the cell wall could be another mechanism behind the increased sensitivity of the pglLBPS mutant
to polymixin B and complement, both of which assemble in the outer membrane.
Cell division is regulated by the assembly of FtsZ subunits at the inner membrane around the circumference
of the bacteria. One suggested mechanism is that this ring constricts, pulling the peptidoglycan-bound outer-
membrane inwards, eventually allowing budding of the daughter cell [46]. Possible disruption of the cell wall in the
pglLBPS mutant may prevent the normal function of the FtsZ ring. Interestingly, mutation of ftsZ causes a similar
filamentous phenotype to the one we observed. Finally, several glycoproteins have been linked with a role in cell
division [47], including FtsZ itself [12], and some of these may be substrates for PglL in B. pseudomallei, as they have
been found to be in B. cenocepacia [11].
Collectively, our in vitro data account for the remarkable attenuation of the pglLBPS mutant in the murine
model of acute melioidosis. Characteristically for B. pseudomallei, even in this severely weakened strain, some of the
infected mice still harbored bacilli in their lungs and spleen despite showing no clinical signs of disease, indicating
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that the bacteria could still disseminate from the site of infection and persist in the host. It is notable that in a
similar study, in which the pilA gene was deleted in B. pseudomallei K96243, attenuation was observed, but not to
the same extent as with deletion of pglL [29]. This, along with our own findings presented here, point to the broad
contribution pglL makes to general cell fitness and virulence beyond a more limited ability to only glycosylate type
IV pilin.
There are numerous reasons why PglLmay function differently in B. pseudomallei compared with B. thailandensis,
and it may depend on how PglL interacts with some of the distinguishing features between the species. For example,
B. thailandensisE264 strain naturally possesses a truncated exopolysaccharide capsule compared withB. pseudomallei
K9264, and some strains lack it entirely [48]. This is likely to account for the heightened complement sensitivity of
wild-type B. thailandensis that we observed compared with wild-type B. pseudomallei [49]. Also, only B. pseudomallei
expresses Type 1 O-antigen in its cell wall [34]. Also, although B. thailandensis possesses orthologous secretion
systems to B. pseudomallei [37,50,51], they are not completely conserved either: while B. pseudomallei has three T3SS,
and T3SS-3 is almost identical in B. thailandensis, T3SS-2 is more dissimilar and T3SS-1 is absent [52].
Although their sequences are well conserved at the amino-acid level, evidence to date suggests that PglL
glycosylates different peptides in either species [14]. In B. pseudomallei, glycosylation of ecotin appears to depend
upon PglL, which may in turn support its function as a protease inhibitor that can modulate neutrophil activity [53].
BPSL3095 was identified as glycosylated in a PglL-dependent manner by Mohamed et al. This is a putative
membrane protein that shares ∼90% nucleic acid sequence identity over ∼50% coverage with some HCP, the
T6SS components that extend through the capsule into the extracellular environment [54]. Although there is so
far no direct evidence linking PglL with glycosylation of HCP, they do possess numerous serine residues in low
complexity regions that suggest they may be permissive substrates. Interestingly,N-linked glycosylation of secretion
system components has been reported [55] and suggested to aid their mechanical stability [56,57]. Cross-linking of
T6SS components with PGN and capsular polysaccharide might support their assembly within the capsule that
might otherwise present a barrier [58–61].
Having demonstrated the critical role of PglL in B. pseudomallei virulence, we also wanted to assess whether
in principal, attenuation would allow the infected host to mount a protective immunological response against
challenge with fully virulent wild-type B. pseudomallei. We found an interesting, dose-dependent effect whereby
too low a dose of pglLBPS in the inoculum was not sufficient to induce significant protection, and too high a dose
resulted in co-infection with both vaccine and challenge strains; a moderate dose ofpglLBPS did result in significant
protection against acute melioidosis. Since sterilising immunity was not achieved in all mice, it would be interesting
to see the effect of a vaccine comprised of deletions at multiple loci, each targeting distinct aspects of B. pseudomallei
virulence. For example, the texRmutant (intracellular growth) [62] and the 2D2mutant (capsular polysaccharide) [63]
have both been shown to attenuate B. pseudomallei, and target post-transcriptional regulation and branched chain
amino acid biosynthesis, respectively. This multi-target approach might make a live-attenuated vaccine against B.
pseudomallei with sterilizing immunity a reality. In addition, given pleiotropic effect of PglL on virulence, inhibiting
this enzyme may be a novel antibiotic target for this naturally multi-antimicrobial resistant pathogen. Our results
are particularly interesting in the context of the natural response to B. pseudomallei infection in humans, whereby
patient sera frequently cross-react with Burkholderia spp. O-glycan, but not with the non-glycosylated version of
the peptide [14]. Combined with our results, this suggests a paradigm whereby O-glycosylation generates products
that are at once immunogenic and required for virulence.
Conclusion
The data presented here represent the first detailed phenotypic characterization of apglLmutant in B. pseudomallei
with the inclusion of a murine model of melioidosis. We also show that PglL has a differing contribution to
virulence in different Burkholderia species. Our findings support previous observations in other species that PglL
can contribute to biofilm formation and twitching motility, and discover a new role that influences some secretion
system-dependent phenotypes in B. pseudomallei, but not in B. thailandensis. Finally, our work demonstrates a
proof of principle that abrogation of protein glycosylation is a valid strategy for the generation of attenuated strains
with the potential for development at a vaccine against melioidosis.
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Summary points
• Burkholderia pseudomallei is a highly virulent opportunistic pathogen of humans, difficult to diagnose and treat,
with no licensed vaccine.
• O-linked OTase glycosylation contribution to virulence has not been explored in this species.
• We delete the pglL gene in a virulent and related avirulent species (Burkholderia pseudomallei and Burkholderia
thailandensis).
• The mutant strains are both defective in twitching motility and biofilm formation.
• Only the B. pseudomallei pglL mutant shows a defect in traits that relate to secretion-system mediated virulence.
• The B. pseudomallei pglL mutant is highly attenuated in an acute model of melioidosis, and moreover can induce
a protective immunological response to subsequent challenge with virulent wild-type B. pseudomallei.
• Deletion of pglL is likely to have pleiotropic effects relating to loss of O-OTase function, and possibly secondary
effects relating to disruption of other pathways that share aspects of the pglL glycosylation pathway.
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